These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 18614276)
1. Regulation of breast cancer-associated aromatase promoters. Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276 [TBL] [Abstract][Full Text] [Related]
2. Regulation of aromatase expression in breast cancer tissue. Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199 [TBL] [Abstract][Full Text] [Related]
3. Organization of the human aromatase p450 (CYP19) gene. Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376 [TBL] [Abstract][Full Text] [Related]
5. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta. Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806 [TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells. Ghosh S; Lu Y; Katz A; Hu Y; Li R Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E246-52. PubMed ID: 16940470 [TBL] [Abstract][Full Text] [Related]
7. Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue. Clyne CD; Kovacic A; Speed CJ; Zhou J; Pezzi V; Simpson ER Mol Cell Endocrinol; 2004 Feb; 215(1-2):39-44. PubMed ID: 15026173 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells. Prosperi JR; Robertson FM Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132 [TBL] [Abstract][Full Text] [Related]
9. Aromatase gene expression in adipose tissue: relationship to breast cancer. Simpson ER; Mahendroo MS; Nichols JE; Bulun SE Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():75-83. PubMed ID: 7874190 [TBL] [Abstract][Full Text] [Related]
10. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Bulun SE; Lin Z; Imir G; Amin S; Demura M; Yilmaz B; Martin R; Utsunomiya H; Thung S; Gurates B; Tamura M; Langoi D; Deb S Pharmacol Rev; 2005 Sep; 57(3):359-83. PubMed ID: 16109840 [TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanism of inhibition of sodium butyrate on activation of tumor associated aromatase promoters]. Zhou JF; Liu WL; Chen G; Lu YP; Ma D Ai Zheng; 2002 Dec; 21(12):1283-7. PubMed ID: 12520731 [TBL] [Abstract][Full Text] [Related]
12. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer. Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304 [TBL] [Abstract][Full Text] [Related]
13. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer. Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283 [TBL] [Abstract][Full Text] [Related]
14. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826 [TBL] [Abstract][Full Text] [Related]
15. Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue. Chen S; Ye J; Kijima I; Kinoshita Y; Zhou D J Steroid Biochem Mol Biol; 2005 May; 95(1-5):17-23. PubMed ID: 15955695 [TBL] [Abstract][Full Text] [Related]
16. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. Shozu M; Sebastian S; Takayama K; Hsu WT; Schultz RA; Neely K; Bryant M; Bulun SE N Engl J Med; 2003 May; 348(19):1855-65. PubMed ID: 12736278 [TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of aromatase in breast cancer tissues. Harada N J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):175-84. PubMed ID: 9365188 [TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer binding protein delta up-regulates aromatase promoters I.3/II in breast cancer epithelial cells. Kijima I; Ye J; Glackin C; Chen S Cancer Res; 2008 Jun; 68(11):4455-64. PubMed ID: 18519709 [TBL] [Abstract][Full Text] [Related]
19. Endocrine disorders associated with inappropriately high aromatase expression. Bulun SE; Noble LS; Takayama K; Michael MD; Agarwal V; Fisher C; Zhao Y; Hinshelwood MM; Ito Y; Simpson ER J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):133-9. PubMed ID: 9365182 [TBL] [Abstract][Full Text] [Related]